• Adrian Simpson, United States says, "If you are looking for a fair deal on medical supplies, IDM is something I would seriously recommend. Am hooked for life."
  • Craig, United States says, "Seemed easy to purchase, reasonable prices. Good customer service when I used it."
  • Brian Pavey, United States says, "IDM makes online shopping a pleasure. Shopping is so simple that you just breeze through it."
  • Harry Mason, United States says, "I have to admit am a bit of a lazy bloke when it comes to ordering online .And IDM pampers me to the hit as it's so simple to order."
  • John Hanks, United States says, "I was a sceptic until my first order. After, I received my first package, I turned believer. Now, it’s been 3 years since I have been ordering from IDM."
  • Natalie Wallace, United States says, "I was apprehensive about how my doubts would be addressed but what the heck,I went ahead and placed my order. Customer service was patient and helped me out."
  • Mark Penning, United States says, "Happy I got my package just in time for my vacation. Needless to say, it made my holiday a wonderfully satisfying experience."
  • Ask our pharmacist, if you have any questions related to your medications
    Click to find International Shipping charges at our pharmacy.
    Shop & Earn @ InternationalDrugMart
    Easy and secure shopping @ InternationalDrugMart.com.
    Get your instant Coupon now!
    You can find the latest happening of our pharmacy
    Follow us on Twitter

      Wockhardt receives USFDA approval for generic version of Augmentin suspension

      Posted AtNews.alibaba.com

      Wockhardt has received USFDA approval for marketing an oral suspension of a combination of amoxycillin and clavulanate potassium. Wockhardt's Chicago-based subsidiary Morton Grove Pharmaceuticals received approval from the USFDA for marketing the suspension containing 250 mg/5 ml of amoxycillin and 62.5 mg/5 ml of clavulanate potassium, which is used for treating several common infections, especially in children. The product is sold in the US by Glaxo SmithKline under the brand name Augmentin 250.

      "Wockhardt is the first company to receive an ANDA approval for this strength of Augmentin. Pediatric products are a major focus area for Morton Grove and this exclusive generic will be one of the several other unique pediatric products in our portfolio," said Habil Khorakiwala, chairman, Wockhardt.

      Wockhardt intends to launch this product in the US sometime in Q3 2009. According to IMS, the market for the 250/62.5 combination of Augmentin in the US is about $ 32 million. The product was developed as a part of a series of collaborative projects along with Cipla Ltd, another pharmaceutical major from India. It will be exclusively manufactured and supplied for Wockhardt by Cipla from its FDA-approved facility in Goa.

      January 09, 2009


      Share this Article!

    Back to top^